AFP and hepatocellular carcinoma: Our results revealed that patients with high serum AFP level (AFP > 400 ng/ml) had poorer OS (P < 0.001) and shorter TTR (P = 0.004), and could be an independent predictor for prognosis in HCC patients (Table 2).